nodes	percent_of_prediction	percent_of_DWPC	metapath
Indacaterol—ABCB1—Methylprednisolone—multiple sclerosis	0.0965	0.124	CbGbCtD
Indacaterol—CYP3A4—Fingolimod—multiple sclerosis	0.0897	0.115	CbGbCtD
Indacaterol—ABCB1—Mitoxantrone—multiple sclerosis	0.0704	0.0901	CbGbCtD
Indacaterol—ABCB1—Betamethasone—multiple sclerosis	0.0627	0.0803	CbGbCtD
Indacaterol—ABCB1—Prednisolone—multiple sclerosis	0.0619	0.0793	CbGbCtD
Indacaterol—ABCB1—Prednisone—multiple sclerosis	0.0585	0.0749	CbGbCtD
Indacaterol—CYP3A4—Methylprednisolone—multiple sclerosis	0.0578	0.074	CbGbCtD
Indacaterol—CYP3A4—Triamcinolone—multiple sclerosis	0.0438	0.0561	CbGbCtD
Indacaterol—CYP3A4—Mitoxantrone—multiple sclerosis	0.0422	0.054	CbGbCtD
Indacaterol—CYP3A4—Betamethasone—multiple sclerosis	0.0376	0.0481	CbGbCtD
Indacaterol—CYP3A4—Prednisolone—multiple sclerosis	0.0371	0.0475	CbGbCtD
Indacaterol—ABCB1—Dexamethasone—multiple sclerosis	0.0365	0.0467	CbGbCtD
Indacaterol—CYP3A4—Prednisone—multiple sclerosis	0.035	0.0449	CbGbCtD
Indacaterol—ABCB1—Methotrexate—multiple sclerosis	0.0293	0.0376	CbGbCtD
Indacaterol—CYP3A4—Dexamethasone—multiple sclerosis	0.0219	0.028	CbGbCtD
Indacaterol—Myocardial ischaemia—Cladribine—multiple sclerosis	0.00388	0.0197	CcSEcCtD
Indacaterol—Chronic obstructive pulmonary disease—Methotrexate—multiple sclerosis	0.00358	0.0182	CcSEcCtD
Indacaterol—Musculoskeletal pain—Cladribine—multiple sclerosis	0.00316	0.0161	CcSEcCtD
Indacaterol—Pneumonia—Fingolimod—multiple sclerosis	0.0031	0.0158	CcSEcCtD
Indacaterol—Infestation NOS—Fingolimod—multiple sclerosis	0.00308	0.0157	CcSEcCtD
Indacaterol—Infestation—Fingolimod—multiple sclerosis	0.00308	0.0157	CcSEcCtD
Indacaterol—Sinusitis—Fingolimod—multiple sclerosis	0.00289	0.0147	CcSEcCtD
Indacaterol—Connective tissue disorder—Fingolimod—multiple sclerosis	0.00272	0.0138	CcSEcCtD
Indacaterol—Cardiac disorder—Fingolimod—multiple sclerosis	0.00257	0.013	CcSEcCtD
Indacaterol—Myocardial ischaemia—Mitoxantrone—multiple sclerosis	0.00255	0.013	CcSEcCtD
Indacaterol—Mediastinal disorder—Fingolimod—multiple sclerosis	0.00249	0.0127	CcSEcCtD
Indacaterol—Atrial fibrillation—Cladribine—multiple sclerosis	0.00239	0.0122	CcSEcCtD
Indacaterol—Palpitations—Fingolimod—multiple sclerosis	0.00213	0.0108	CcSEcCtD
Indacaterol—Cough—Fingolimod—multiple sclerosis	0.0021	0.0107	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Fingolimod—multiple sclerosis	0.00204	0.0103	CcSEcCtD
Indacaterol—Infection—Fingolimod—multiple sclerosis	0.00195	0.00992	CcSEcCtD
Indacaterol—Nervous system disorder—Fingolimod—multiple sclerosis	0.00193	0.0098	CcSEcCtD
Indacaterol—Skin disorder—Fingolimod—multiple sclerosis	0.00191	0.0097	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Cladribine—multiple sclerosis	0.00182	0.00925	CcSEcCtD
Indacaterol—Paraesthesia—Fingolimod—multiple sclerosis	0.00176	0.00897	CcSEcCtD
Indacaterol—Pneumonia—Cladribine—multiple sclerosis	0.00176	0.00893	CcSEcCtD
Indacaterol—Dyspnoea—Fingolimod—multiple sclerosis	0.00175	0.00891	CcSEcCtD
Indacaterol—Infestation NOS—Cladribine—multiple sclerosis	0.00175	0.00888	CcSEcCtD
Indacaterol—Infestation—Cladribine—multiple sclerosis	0.00175	0.00888	CcSEcCtD
Indacaterol—Oropharyngeal pain—Triamcinolone—multiple sclerosis	0.0017	0.00866	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.0017	0.00862	CcSEcCtD
Indacaterol—Oedema peripheral—Cladribine—multiple sclerosis	0.00154	0.00785	CcSEcCtD
Indacaterol—Connective tissue disorder—Cladribine—multiple sclerosis	0.00154	0.00783	CcSEcCtD
Indacaterol—Cardiac disorder—Cladribine—multiple sclerosis	0.00145	0.0074	CcSEcCtD
Indacaterol—Pneumonia—Azathioprine—multiple sclerosis	0.00143	0.00726	CcSEcCtD
Indacaterol—Infestation NOS—Azathioprine—multiple sclerosis	0.00142	0.00722	CcSEcCtD
Indacaterol—Infestation—Azathioprine—multiple sclerosis	0.00142	0.00722	CcSEcCtD
Indacaterol—Immune system disorder—Cladribine—multiple sclerosis	0.00142	0.0072	CcSEcCtD
Indacaterol—Mediastinal disorder—Cladribine—multiple sclerosis	0.00141	0.00718	CcSEcCtD
Indacaterol—Diabetes mellitus—Prednisolone—multiple sclerosis	0.0014	0.00714	CcSEcCtD
Indacaterol—Pruritus—Fingolimod—multiple sclerosis	0.00139	0.00707	CcSEcCtD
Indacaterol—Malnutrition—Cladribine—multiple sclerosis	0.00136	0.00694	CcSEcCtD
Indacaterol—Hypokalaemia—Mitoxantrone—multiple sclerosis	0.00136	0.00689	CcSEcCtD
Indacaterol—Dizziness—Fingolimod—multiple sclerosis	0.0013	0.00661	CcSEcCtD
Indacaterol—Diabetes mellitus—Triamcinolone—multiple sclerosis	0.00129	0.00657	CcSEcCtD
Indacaterol—Diabetes mellitus—Methylprednisolone—multiple sclerosis	0.00129	0.00655	CcSEcCtD
Indacaterol—Anaemia—Cladribine—multiple sclerosis	0.00126	0.00641	CcSEcCtD
Indacaterol—Headache—Fingolimod—multiple sclerosis	0.00123	0.00626	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Mitoxantrone—multiple sclerosis	0.0012	0.00608	CcSEcCtD
Indacaterol—Cough—Cladribine—multiple sclerosis	0.00119	0.00605	CcSEcCtD
Indacaterol—Diabetes mellitus—Betamethasone—multiple sclerosis	0.00117	0.00596	CcSEcCtD
Indacaterol—Diabetes mellitus—Dexamethasone—multiple sclerosis	0.00117	0.00596	CcSEcCtD
Indacaterol—Chest pain—Cladribine—multiple sclerosis	0.00116	0.00591	CcSEcCtD
Indacaterol—Myalgia—Cladribine—multiple sclerosis	0.00116	0.00591	CcSEcCtD
Indacaterol—Hyperglycaemia—Mitoxantrone—multiple sclerosis	0.00116	0.0059	CcSEcCtD
Indacaterol—Pneumonia—Mitoxantrone—multiple sclerosis	0.00115	0.00587	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.00115	0.00587	CcSEcCtD
Indacaterol—Immune system disorder—Azathioprine—multiple sclerosis	0.00115	0.00585	CcSEcCtD
Indacaterol—Mediastinal disorder—Azathioprine—multiple sclerosis	0.00115	0.00584	CcSEcCtD
Indacaterol—Infection—Cladribine—multiple sclerosis	0.00111	0.00563	CcSEcCtD
Indacaterol—Nervous system disorder—Cladribine—multiple sclerosis	0.00109	0.00555	CcSEcCtD
Indacaterol—Tachycardia—Cladribine—multiple sclerosis	0.00109	0.00553	CcSEcCtD
Indacaterol—Skin disorder—Cladribine—multiple sclerosis	0.00108	0.0055	CcSEcCtD
Indacaterol—Sinusitis—Mitoxantrone—multiple sclerosis	0.00108	0.00548	CcSEcCtD
Indacaterol—Anaemia—Azathioprine—multiple sclerosis	0.00103	0.00521	CcSEcCtD
Indacaterol—Diabetes mellitus—Prednisone—multiple sclerosis	0.00102	0.00519	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.00101	0.00516	CcSEcCtD
Indacaterol—Paraesthesia—Cladribine—multiple sclerosis	0.001	0.00508	CcSEcCtD
Indacaterol—Dyspnoea—Cladribine—multiple sclerosis	0.000993	0.00505	CcSEcCtD
Indacaterol—Asthma—Triamcinolone—multiple sclerosis	0.000971	0.00494	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000961	0.00489	CcSEcCtD
Indacaterol—Bronchospasm—Methylprednisolone—multiple sclerosis	0.000953	0.00485	CcSEcCtD
Indacaterol—Myalgia—Azathioprine—multiple sclerosis	0.000945	0.0048	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.000938	0.00477	CcSEcCtD
Indacaterol—Hypokalaemia—Dexamethasone—multiple sclerosis	0.000928	0.00472	CcSEcCtD
Indacaterol—Hypokalaemia—Betamethasone—multiple sclerosis	0.000928	0.00472	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Triamcinolone—multiple sclerosis	0.000903	0.00459	CcSEcCtD
Indacaterol—Infection—Azathioprine—multiple sclerosis	0.0009	0.00457	CcSEcCtD
Indacaterol—Skin disorder—Azathioprine—multiple sclerosis	0.00088	0.00447	CcSEcCtD
Indacaterol—Infestation—Methylprednisolone—multiple sclerosis	0.000864	0.00439	CcSEcCtD
Indacaterol—Infestation NOS—Methylprednisolone—multiple sclerosis	0.000864	0.00439	CcSEcCtD
Indacaterol—Diabetes mellitus—Methotrexate—multiple sclerosis	0.000853	0.00434	CcSEcCtD
Indacaterol—Anaemia—Mitoxantrone—multiple sclerosis	0.000829	0.00422	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000825	0.00419	CcSEcCtD
Indacaterol—Hypersensitivity—Cladribine—multiple sclerosis	0.00082	0.00417	CcSEcCtD
Indacaterol—Hypokalaemia—Prednisone—multiple sclerosis	0.000808	0.00411	CcSEcCtD
Indacaterol—Hyperglycaemia—Betamethasone—multiple sclerosis	0.000795	0.00404	CcSEcCtD
Indacaterol—Hyperglycaemia—Dexamethasone—multiple sclerosis	0.000795	0.00404	CcSEcCtD
Indacaterol—Pruritus—Cladribine—multiple sclerosis	0.000788	0.00401	CcSEcCtD
Indacaterol—Cough—Mitoxantrone—multiple sclerosis	0.000783	0.00398	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000782	0.00397	CcSEcCtD
Indacaterol—Myalgia—Mitoxantrone—multiple sclerosis	0.000764	0.00388	CcSEcCtD
Indacaterol—Chest pain—Mitoxantrone—multiple sclerosis	0.000764	0.00388	CcSEcCtD
Indacaterol—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.000762	0.00388	CcSEcCtD
Indacaterol—Dizziness—Cladribine—multiple sclerosis	0.000736	0.00374	CcSEcCtD
Indacaterol—Infection—Mitoxantrone—multiple sclerosis	0.000727	0.0037	CcSEcCtD
Indacaterol—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.00072	0.00366	CcSEcCtD
Indacaterol—Tachycardia—Mitoxantrone—multiple sclerosis	0.000714	0.00363	CcSEcCtD
Indacaterol—Skin disorder—Mitoxantrone—multiple sclerosis	0.000711	0.00362	CcSEcCtD
Indacaterol—Rash—Cladribine—multiple sclerosis	0.000702	0.00357	CcSEcCtD
Indacaterol—Dermatitis—Cladribine—multiple sclerosis	0.000702	0.00357	CcSEcCtD
Indacaterol—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000701	0.00356	CcSEcCtD
Indacaterol—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000699	0.00355	CcSEcCtD
Indacaterol—Headache—Cladribine—multiple sclerosis	0.000698	0.00355	CcSEcCtD
Indacaterol—Hyperglycaemia—Prednisone—multiple sclerosis	0.000692	0.00352	CcSEcCtD
Indacaterol—Malnutrition—Methylprednisolone—multiple sclerosis	0.000675	0.00343	CcSEcCtD
Indacaterol—Hypersensitivity—Azathioprine—multiple sclerosis	0.000667	0.00339	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000667	0.00339	CcSEcCtD
Indacaterol—Nausea—Cladribine—multiple sclerosis	0.000661	0.00336	CcSEcCtD
Indacaterol—Vertigo—Prednisolone—multiple sclerosis	0.000661	0.00336	CcSEcCtD
Indacaterol—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000657	0.00334	CcSEcCtD
Indacaterol—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000653	0.00332	CcSEcCtD
Indacaterol—Asthma—Methotrexate—multiple sclerosis	0.000641	0.00326	CcSEcCtD
Indacaterol—Vertigo—Triamcinolone—multiple sclerosis	0.000608	0.00309	CcSEcCtD
Indacaterol—Vertigo—Methylprednisolone—multiple sclerosis	0.000607	0.00308	CcSEcCtD
Indacaterol—Connective tissue disorder—Prednisone—multiple sclerosis	0.000604	0.00307	CcSEcCtD
Indacaterol—Dizziness—Azathioprine—multiple sclerosis	0.000599	0.00304	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000596	0.00303	CcSEcCtD
Indacaterol—Cough—Triamcinolone—multiple sclerosis	0.00059	0.003	CcSEcCtD
Indacaterol—Tachycardia—Prednisolone—multiple sclerosis	0.000586	0.00298	CcSEcCtD
Indacaterol—Myalgia—Triamcinolone—multiple sclerosis	0.000576	0.00293	CcSEcCtD
Indacaterol—Pneumonia—Methotrexate—multiple sclerosis	0.000575	0.00292	CcSEcCtD
Indacaterol—Myalgia—Methylprednisolone—multiple sclerosis	0.000575	0.00292	CcSEcCtD
Indacaterol—Infestation NOS—Methotrexate—multiple sclerosis	0.000572	0.00291	CcSEcCtD
Indacaterol—Infestation—Methotrexate—multiple sclerosis	0.000572	0.00291	CcSEcCtD
Indacaterol—Rash—Azathioprine—multiple sclerosis	0.000571	0.0029	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000571	0.0029	CcSEcCtD
Indacaterol—Dermatitis—Azathioprine—multiple sclerosis	0.00057	0.0029	CcSEcCtD
Indacaterol—Headache—Azathioprine—multiple sclerosis	0.000567	0.00288	CcSEcCtD
Indacaterol—Dry mouth—Triamcinolone—multiple sclerosis	0.000563	0.00286	CcSEcCtD
Indacaterol—Immune system disorder—Prednisone—multiple sclerosis	0.000555	0.00282	CcSEcCtD
Indacaterol—Vertigo—Betamethasone—multiple sclerosis	0.000552	0.0028	CcSEcCtD
Indacaterol—Vertigo—Dexamethasone—multiple sclerosis	0.000552	0.0028	CcSEcCtD
Indacaterol—Infection—Triamcinolone—multiple sclerosis	0.000549	0.00279	CcSEcCtD
Indacaterol—Infection—Methylprednisolone—multiple sclerosis	0.000547	0.00278	CcSEcCtD
Indacaterol—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.00054	0.00275	CcSEcCtD
Indacaterol—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000539	0.00274	CcSEcCtD
Indacaterol—Paraesthesia—Prednisolone—multiple sclerosis	0.000539	0.00274	CcSEcCtD
Indacaterol—Tachycardia—Triamcinolone—multiple sclerosis	0.000539	0.00274	CcSEcCtD
Indacaterol—Nausea—Azathioprine—multiple sclerosis	0.000538	0.00273	CcSEcCtD
Indacaterol—Tachycardia—Methylprednisolone—multiple sclerosis	0.000538	0.00273	CcSEcCtD
Indacaterol—Skin disorder—Methylprednisolone—multiple sclerosis	0.000535	0.00272	CcSEcCtD
Indacaterol—Malnutrition—Prednisone—multiple sclerosis	0.000535	0.00272	CcSEcCtD
Indacaterol—Myalgia—Betamethasone—multiple sclerosis	0.000523	0.00266	CcSEcCtD
Indacaterol—Myalgia—Dexamethasone—multiple sclerosis	0.000523	0.00266	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000503	0.00256	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000502	0.00255	CcSEcCtD
Indacaterol—Infection—Betamethasone—multiple sclerosis	0.000498	0.00253	CcSEcCtD
Indacaterol—Infection—Dexamethasone—multiple sclerosis	0.000498	0.00253	CcSEcCtD
Indacaterol—Paraesthesia—Triamcinolone—multiple sclerosis	0.000496	0.00252	CcSEcCtD
Indacaterol—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000495	0.00252	CcSEcCtD
Indacaterol—Anaemia—Prednisone—multiple sclerosis	0.000494	0.00251	CcSEcCtD
Indacaterol—Dyspnoea—Triamcinolone—multiple sclerosis	0.000492	0.0025	CcSEcCtD
Indacaterol—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000491	0.0025	CcSEcCtD
Indacaterol—Nervous system disorder—Betamethasone—multiple sclerosis	0.000491	0.0025	CcSEcCtD
Indacaterol—Tachycardia—Dexamethasone—multiple sclerosis	0.000489	0.00249	CcSEcCtD
Indacaterol—Tachycardia—Betamethasone—multiple sclerosis	0.000489	0.00249	CcSEcCtD
Indacaterol—Vertigo—Prednisone—multiple sclerosis	0.00048	0.00244	CcSEcCtD
Indacaterol—Cardiac disorder—Methotrexate—multiple sclerosis	0.000476	0.00242	CcSEcCtD
Indacaterol—Immune system disorder—Methotrexate—multiple sclerosis	0.000464	0.00236	CcSEcCtD
Indacaterol—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000463	0.00235	CcSEcCtD
Indacaterol—Rash—Mitoxantrone—multiple sclerosis	0.000462	0.00235	CcSEcCtD
Indacaterol—Dermatitis—Mitoxantrone—multiple sclerosis	0.000461	0.00234	CcSEcCtD
Indacaterol—Headache—Mitoxantrone—multiple sclerosis	0.000459	0.00233	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000457	0.00232	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000457	0.00232	CcSEcCtD
Indacaterol—Myalgia—Prednisone—multiple sclerosis	0.000455	0.00231	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000452	0.0023	CcSEcCtD
Indacaterol—Paraesthesia—Betamethasone—multiple sclerosis	0.00045	0.00229	CcSEcCtD
Indacaterol—Paraesthesia—Dexamethasone—multiple sclerosis	0.00045	0.00229	CcSEcCtD
Indacaterol—Malnutrition—Methotrexate—multiple sclerosis	0.000447	0.00227	CcSEcCtD
Indacaterol—Hypersensitivity—Prednisolone—multiple sclerosis	0.000442	0.00225	CcSEcCtD
Indacaterol—Nausea—Mitoxantrone—multiple sclerosis	0.000435	0.00221	CcSEcCtD
Indacaterol—Infection—Prednisone—multiple sclerosis	0.000434	0.0022	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000433	0.0022	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000433	0.0022	CcSEcCtD
Indacaterol—Nervous system disorder—Prednisone—multiple sclerosis	0.000428	0.00218	CcSEcCtD
Indacaterol—Tachycardia—Prednisone—multiple sclerosis	0.000426	0.00217	CcSEcCtD
Indacaterol—Skin disorder—Prednisone—multiple sclerosis	0.000424	0.00216	CcSEcCtD
Indacaterol—Anaemia—Methotrexate—multiple sclerosis	0.000413	0.0021	CcSEcCtD
Indacaterol—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000407	0.00207	CcSEcCtD
Indacaterol—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000406	0.00206	CcSEcCtD
Indacaterol—Vertigo—Methotrexate—multiple sclerosis	0.000401	0.00204	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000398	0.00202	CcSEcCtD
Indacaterol—Dizziness—Prednisolone—multiple sclerosis	0.000397	0.00202	CcSEcCtD
Indacaterol—Paraesthesia—Prednisone—multiple sclerosis	0.000392	0.00199	CcSEcCtD
Indacaterol—Pruritus—Triamcinolone—multiple sclerosis	0.000391	0.00199	CcSEcCtD
Indacaterol—Cough—Methotrexate—multiple sclerosis	0.00039	0.00198	CcSEcCtD
Indacaterol—Pruritus—Methylprednisolone—multiple sclerosis	0.00039	0.00198	CcSEcCtD
Indacaterol—Myalgia—Methotrexate—multiple sclerosis	0.00038	0.00193	CcSEcCtD
Indacaterol—Chest pain—Methotrexate—multiple sclerosis	0.00038	0.00193	CcSEcCtD
Indacaterol—Rash—Prednisolone—multiple sclerosis	0.000379	0.00193	CcSEcCtD
Indacaterol—Dermatitis—Prednisolone—multiple sclerosis	0.000378	0.00192	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000378	0.00192	CcSEcCtD
Indacaterol—Headache—Prednisolone—multiple sclerosis	0.000376	0.00191	CcSEcCtD
Indacaterol—Dizziness—Triamcinolone—multiple sclerosis	0.000365	0.00186	CcSEcCtD
Indacaterol—Dizziness—Methylprednisolone—multiple sclerosis	0.000364	0.00185	CcSEcCtD
Indacaterol—Infection—Methotrexate—multiple sclerosis	0.000362	0.00184	CcSEcCtD
Indacaterol—Nervous system disorder—Methotrexate—multiple sclerosis	0.000358	0.00182	CcSEcCtD
Indacaterol—Nausea—Prednisolone—multiple sclerosis	0.000357	0.00181	CcSEcCtD
Indacaterol—Pruritus—Dexamethasone—multiple sclerosis	0.000355	0.0018	CcSEcCtD
Indacaterol—Pruritus—Betamethasone—multiple sclerosis	0.000355	0.0018	CcSEcCtD
Indacaterol—Skin disorder—Methotrexate—multiple sclerosis	0.000354	0.0018	CcSEcCtD
Indacaterol—Rash—Triamcinolone—multiple sclerosis	0.000348	0.00177	CcSEcCtD
Indacaterol—Dermatitis—Triamcinolone—multiple sclerosis	0.000348	0.00177	CcSEcCtD
Indacaterol—Rash—Methylprednisolone—multiple sclerosis	0.000347	0.00177	CcSEcCtD
Indacaterol—Dermatitis—Methylprednisolone—multiple sclerosis	0.000347	0.00176	CcSEcCtD
Indacaterol—Headache—Triamcinolone—multiple sclerosis	0.000346	0.00176	CcSEcCtD
Indacaterol—Headache—Methylprednisolone—multiple sclerosis	0.000345	0.00176	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000332	0.00169	CcSEcCtD
Indacaterol—Dizziness—Dexamethasone—multiple sclerosis	0.000331	0.00168	CcSEcCtD
Indacaterol—Dizziness—Betamethasone—multiple sclerosis	0.000331	0.00168	CcSEcCtD
Indacaterol—Nausea—Triamcinolone—multiple sclerosis	0.000328	0.00167	CcSEcCtD
Indacaterol—Paraesthesia—Methotrexate—multiple sclerosis	0.000327	0.00167	CcSEcCtD
Indacaterol—Nausea—Methylprednisolone—multiple sclerosis	0.000327	0.00166	CcSEcCtD
Indacaterol—Dyspnoea—Methotrexate—multiple sclerosis	0.000325	0.00165	CcSEcCtD
Indacaterol—Hypersensitivity—Prednisone—multiple sclerosis	0.000322	0.00163	CcSEcCtD
Indacaterol—Rash—Dexamethasone—multiple sclerosis	0.000316	0.00161	CcSEcCtD
Indacaterol—Rash—Betamethasone—multiple sclerosis	0.000316	0.00161	CcSEcCtD
Indacaterol—Dermatitis—Betamethasone—multiple sclerosis	0.000316	0.00161	CcSEcCtD
Indacaterol—Dermatitis—Dexamethasone—multiple sclerosis	0.000316	0.00161	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000315	0.0016	CcSEcCtD
Indacaterol—Headache—Dexamethasone—multiple sclerosis	0.000314	0.0016	CcSEcCtD
Indacaterol—Headache—Betamethasone—multiple sclerosis	0.000314	0.0016	CcSEcCtD
Indacaterol—Pruritus—Prednisone—multiple sclerosis	0.000309	0.00157	CcSEcCtD
Indacaterol—Nausea—Dexamethasone—multiple sclerosis	0.000298	0.00151	CcSEcCtD
Indacaterol—Nausea—Betamethasone—multiple sclerosis	0.000298	0.00151	CcSEcCtD
Indacaterol—Dizziness—Prednisone—multiple sclerosis	0.000289	0.00147	CcSEcCtD
Indacaterol—Rash—Prednisone—multiple sclerosis	0.000275	0.0014	CcSEcCtD
Indacaterol—Dermatitis—Prednisone—multiple sclerosis	0.000275	0.0014	CcSEcCtD
Indacaterol—Headache—Prednisone—multiple sclerosis	0.000273	0.00139	CcSEcCtD
Indacaterol—Hypersensitivity—Methotrexate—multiple sclerosis	0.000269	0.00137	CcSEcCtD
Indacaterol—Nausea—Prednisone—multiple sclerosis	0.000259	0.00132	CcSEcCtD
Indacaterol—Pruritus—Methotrexate—multiple sclerosis	0.000258	0.00131	CcSEcCtD
Indacaterol—Dizziness—Methotrexate—multiple sclerosis	0.000241	0.00123	CcSEcCtD
Indacaterol—Rash—Methotrexate—multiple sclerosis	0.00023	0.00117	CcSEcCtD
Indacaterol—Dermatitis—Methotrexate—multiple sclerosis	0.00023	0.00117	CcSEcCtD
Indacaterol—Headache—Methotrexate—multiple sclerosis	0.000228	0.00116	CcSEcCtD
Indacaterol—Nausea—Methotrexate—multiple sclerosis	0.000217	0.0011	CcSEcCtD
Indacaterol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	8.38e-05	0.00373	CbGpPWpGaD
Indacaterol—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	8.32e-05	0.0037	CbGpPWpGaD
Indacaterol—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	8.32e-05	0.0037	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—CXCL13—multiple sclerosis	8.3e-05	0.00369	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—CCR1—multiple sclerosis	8.3e-05	0.00369	CbGpPWpGaD
Indacaterol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	8.2e-05	0.00365	CbGpPWpGaD
Indacaterol—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	8.2e-05	0.00365	CbGpPWpGaD
Indacaterol—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	8.2e-05	0.00365	CbGpPWpGaD
Indacaterol—ABCB1—Allograft Rejection—CD86—multiple sclerosis	8.16e-05	0.00363	CbGpPWpGaD
Indacaterol—ABCB1—Allograft Rejection—IL10—multiple sclerosis	8e-05	0.00356	CbGpPWpGaD
Indacaterol—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	8e-05	0.00356	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	7.94e-05	0.00353	CbGpPWpGaD
Indacaterol—ABCB1—Allograft Rejection—IL4—multiple sclerosis	7.79e-05	0.00346	CbGpPWpGaD
Indacaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	7.77e-05	0.00346	CbGpPWpGaD
Indacaterol—ADRB1—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	7.74e-05	0.00344	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	7.65e-05	0.0034	CbGpPWpGaD
Indacaterol—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	7.61e-05	0.00339	CbGpPWpGaD
Indacaterol—ADRB1—G alpha (s) signalling events—POMC—multiple sclerosis	7.59e-05	0.00338	CbGpPWpGaD
Indacaterol—ADRB2—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	7.57e-05	0.00337	CbGpPWpGaD
Indacaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	7.48e-05	0.00333	CbGpPWpGaD
Indacaterol—ADRB2—G alpha (s) signalling events—POMC—multiple sclerosis	7.42e-05	0.0033	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	7.38e-05	0.00328	CbGpPWpGaD
Indacaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	7.22e-05	0.00321	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	7.18e-05	0.0032	CbGpPWpGaD
Indacaterol—ABCB1—Allograft Rejection—FAS—multiple sclerosis	7.18e-05	0.00319	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—SRM—multiple sclerosis	7.14e-05	0.00318	CbGpPWpGaD
Indacaterol—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	7.13e-05	0.00317	CbGpPWpGaD
Indacaterol—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	7.05e-05	0.00314	CbGpPWpGaD
Indacaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	7.03e-05	0.00313	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	6.63e-05	0.00295	CbGpPWpGaD
Indacaterol—UGT1A1—Biological oxidations—POMC—multiple sclerosis	6.62e-05	0.00294	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—S1PR1—multiple sclerosis	6.51e-05	0.00289	CbGpPWpGaD
Indacaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	6.48e-05	0.00288	CbGpPWpGaD
Indacaterol—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	6.44e-05	0.00287	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—S1PR1—multiple sclerosis	6.37e-05	0.00283	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—CCL3—multiple sclerosis	6.05e-05	0.00269	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	5.97e-05	0.00266	CbGpPWpGaD
Indacaterol—ABCB1—Allograft Rejection—CD80—multiple sclerosis	5.95e-05	0.00265	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—CCL3—multiple sclerosis	5.92e-05	0.00263	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—S1PR1—multiple sclerosis	5.91e-05	0.00263	CbGpPWpGaD
Indacaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	5.84e-05	0.0026	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—PTGER4—multiple sclerosis	5.82e-05	0.00259	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—S1PR1—multiple sclerosis	5.78e-05	0.00257	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—PTGER4—multiple sclerosis	5.7e-05	0.00253	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—CXCR3—multiple sclerosis	5.62e-05	0.0025	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—RGS1—multiple sclerosis	5.53e-05	0.00246	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—CXCR3—multiple sclerosis	5.5e-05	0.00245	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—CCR2—multiple sclerosis	5.47e-05	0.00243	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—RGS1—multiple sclerosis	5.41e-05	0.00241	CbGpPWpGaD
Indacaterol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	5.4e-05	0.0024	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—CCR2—multiple sclerosis	5.35e-05	0.00238	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.3e-05	0.00236	CbGpPWpGaD
Indacaterol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	5.28e-05	0.00235	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—GPR65—multiple sclerosis	5.24e-05	0.00233	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	5.15e-05	0.00229	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	5.14e-05	0.00229	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—GPR65—multiple sclerosis	5.13e-05	0.00228	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—CNR1—multiple sclerosis	5.05e-05	0.00225	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—CYP27B1—multiple sclerosis	5.03e-05	0.00224	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—CYP24A1—multiple sclerosis	5.03e-05	0.00224	CbGpPWpGaD
Indacaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	5.03e-05	0.00224	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—RGS1—multiple sclerosis	5.02e-05	0.00224	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—CNR1—multiple sclerosis	4.94e-05	0.0022	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—RGS1—multiple sclerosis	4.91e-05	0.00219	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—CXCL13—multiple sclerosis	4.8e-05	0.00213	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—CCR1—multiple sclerosis	4.8e-05	0.00213	CbGpPWpGaD
Indacaterol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	4.79e-05	0.00213	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—GPR65—multiple sclerosis	4.76e-05	0.00212	CbGpPWpGaD
Indacaterol—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	4.71e-05	0.00209	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—CXCL13—multiple sclerosis	4.69e-05	0.00209	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—CCR1—multiple sclerosis	4.69e-05	0.00209	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—GPR65—multiple sclerosis	4.66e-05	0.00207	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	4.63e-05	0.00206	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—LINGO1—multiple sclerosis	4.61e-05	0.00205	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—GPC5—multiple sclerosis	4.6e-05	0.00205	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—CXCL10—multiple sclerosis	4.55e-05	0.00202	CbGpPWpGaD
Indacaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	4.53e-05	0.00201	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—LINGO1—multiple sclerosis	4.51e-05	0.002	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—CXCL10—multiple sclerosis	4.45e-05	0.00198	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—CXCL13—multiple sclerosis	4.36e-05	0.00194	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—CCR1—multiple sclerosis	4.36e-05	0.00194	CbGpPWpGaD
Indacaterol—UGT1A1—NRF2 pathway—TGFB1—multiple sclerosis	4.35e-05	0.00194	CbGpPWpGaD
Indacaterol—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.34e-05	0.00193	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—CXCL13—multiple sclerosis	4.26e-05	0.0019	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—CCR1—multiple sclerosis	4.26e-05	0.0019	CbGpPWpGaD
Indacaterol—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	4.2e-05	0.00187	CbGpPWpGaD
Indacaterol—ABCB1—Allograft Rejection—IL2—multiple sclerosis	4.18e-05	0.00186	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	4.14e-05	0.00184	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.02e-05	0.00179	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—TAGAP—multiple sclerosis	3.99e-05	0.00178	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—CCL5—multiple sclerosis	3.91e-05	0.00174	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—TAGAP—multiple sclerosis	3.91e-05	0.00174	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—CCL5—multiple sclerosis	3.83e-05	0.0017	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—RRM1—multiple sclerosis	3.81e-05	0.0017	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	3.62e-05	0.00161	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	3.54e-05	0.00158	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	3.54e-05	0.00157	CbGpPWpGaD
Indacaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	3.54e-05	0.00157	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—CCR5—multiple sclerosis	3.52e-05	0.00157	CbGpPWpGaD
Indacaterol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.52e-05	0.00157	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—S1PR1—multiple sclerosis	3.49e-05	0.00155	CbGpPWpGaD
Indacaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	3.46e-05	0.00154	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—CCR5—multiple sclerosis	3.45e-05	0.00153	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—S1PR1—multiple sclerosis	3.41e-05	0.00152	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—GPC5—multiple sclerosis	3.4e-05	0.00151	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—GPC5—multiple sclerosis	3.32e-05	0.00148	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—PTGER4—multiple sclerosis	3.29e-05	0.00146	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—SRM—multiple sclerosis	3.28e-05	0.00146	CbGpPWpGaD
Indacaterol—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	3.26e-05	0.00145	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—PTGER4—multiple sclerosis	3.22e-05	0.00143	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—CXCR3—multiple sclerosis	3.18e-05	0.00141	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.18e-05	0.00141	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—CXCR3—multiple sclerosis	3.11e-05	0.00138	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—CCL3—multiple sclerosis	3.1e-05	0.00138	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—CCR2—multiple sclerosis	3.09e-05	0.00138	CbGpPWpGaD
Indacaterol—ABCB1—Allograft Rejection—TNF—multiple sclerosis	3.05e-05	0.00136	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—CCL3—multiple sclerosis	3.04e-05	0.00135	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—CCR2—multiple sclerosis	3.02e-05	0.00135	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PTGER4—multiple sclerosis	2.99e-05	0.00133	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—RGS1—multiple sclerosis	2.97e-05	0.00132	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PTGER4—multiple sclerosis	2.92e-05	0.0013	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—RGS1—multiple sclerosis	2.9e-05	0.00129	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—CXCR3—multiple sclerosis	2.89e-05	0.00128	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—CNR1—multiple sclerosis	2.85e-05	0.00127	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—CXCR3—multiple sclerosis	2.82e-05	0.00126	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—GPR65—multiple sclerosis	2.81e-05	0.00125	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.81e-05	0.00125	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—CCR2—multiple sclerosis	2.81e-05	0.00125	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—CNR1—multiple sclerosis	2.79e-05	0.00124	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—POMC—multiple sclerosis	2.75e-05	0.00123	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—GPR65—multiple sclerosis	2.75e-05	0.00122	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—CCR2—multiple sclerosis	2.75e-05	0.00122	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—CCL2—multiple sclerosis	2.7e-05	0.0012	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—POMC—multiple sclerosis	2.69e-05	0.0012	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—CCL2—multiple sclerosis	2.64e-05	0.00117	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—CNR1—multiple sclerosis	2.59e-05	0.00115	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CXCL13—multiple sclerosis	2.57e-05	0.00114	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CCR1—multiple sclerosis	2.57e-05	0.00114	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—CXCL10—multiple sclerosis	2.57e-05	0.00114	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—CNR1—multiple sclerosis	2.53e-05	0.00113	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CCR1—multiple sclerosis	2.52e-05	0.00112	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CXCL13—multiple sclerosis	2.52e-05	0.00112	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—CXCL10—multiple sclerosis	2.51e-05	0.00112	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—CXCL10—multiple sclerosis	2.33e-05	0.00104	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CYP27B1—multiple sclerosis	2.31e-05	0.00103	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CYP24A1—multiple sclerosis	2.31e-05	0.00103	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—CXCL10—multiple sclerosis	2.28e-05	0.00102	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—CCL5—multiple sclerosis	2.21e-05	0.000984	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—BCHE—multiple sclerosis	2.19e-05	0.000974	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—CCL5—multiple sclerosis	2.16e-05	0.000962	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GPC5—multiple sclerosis	2.11e-05	0.000939	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—SRM—multiple sclerosis	2.02e-05	0.000898	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—CCL5—multiple sclerosis	2.01e-05	0.000893	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—CCR5—multiple sclerosis	1.99e-05	0.000886	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—CCL5—multiple sclerosis	1.96e-05	0.000874	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—IL2RA—multiple sclerosis	1.96e-05	0.000873	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—CCR5—multiple sclerosis	1.95e-05	0.000867	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—IL2RA—multiple sclerosis	1.92e-05	0.000854	CbGpPWpGaD
Indacaterol—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.87e-05	0.000832	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CCL3—multiple sclerosis	1.83e-05	0.000816	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—CCR5—multiple sclerosis	1.81e-05	0.000805	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CCL3—multiple sclerosis	1.79e-05	0.000798	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—IL2RA—multiple sclerosis	1.78e-05	0.000793	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—CCR5—multiple sclerosis	1.77e-05	0.000787	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PTGER4—multiple sclerosis	1.77e-05	0.000785	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—RRM1—multiple sclerosis	1.75e-05	0.000778	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—IL2RA—multiple sclerosis	1.74e-05	0.000776	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PGR—multiple sclerosis	1.74e-05	0.000773	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PTGER4—multiple sclerosis	1.73e-05	0.000768	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CXCR3—multiple sclerosis	1.7e-05	0.000758	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PGR—multiple sclerosis	1.7e-05	0.000756	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CD28—multiple sclerosis	1.69e-05	0.000751	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CXCR3—multiple sclerosis	1.67e-05	0.000742	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CCR2—multiple sclerosis	1.66e-05	0.000738	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CD28—multiple sclerosis	1.65e-05	0.000735	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CCR2—multiple sclerosis	1.62e-05	0.000722	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.61e-05	0.000718	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.61e-05	0.000716	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.58e-05	0.000702	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—POMC—multiple sclerosis	1.56e-05	0.000693	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CNR1—multiple sclerosis	1.53e-05	0.000681	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—POMC—multiple sclerosis	1.52e-05	0.000677	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.5e-05	0.000669	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CNR1—multiple sclerosis	1.5e-05	0.000666	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.42e-05	0.000633	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.42e-05	0.000633	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—POMC—multiple sclerosis	1.41e-05	0.000629	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—CCL2—multiple sclerosis	1.38e-05	0.000615	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—POMC—multiple sclerosis	1.38e-05	0.000615	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CXCL10—multiple sclerosis	1.38e-05	0.000613	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—CCL2—multiple sclerosis	1.35e-05	0.000602	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CXCL10—multiple sclerosis	1.35e-05	0.0006	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—APOE—multiple sclerosis	1.32e-05	0.000586	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.3e-05	0.000579	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—TYK2—multiple sclerosis	1.26e-05	0.000559	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—TYK2—multiple sclerosis	1.23e-05	0.000547	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CD86—multiple sclerosis	1.2e-05	0.000536	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CCL5—multiple sclerosis	1.19e-05	0.000528	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CD86—multiple sclerosis	1.18e-05	0.000524	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CCL5—multiple sclerosis	1.16e-05	0.000516	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—IL2—multiple sclerosis	1.15e-05	0.000512	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—POMC—multiple sclerosis	1.13e-05	0.000504	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—IL2—multiple sclerosis	1.13e-05	0.000501	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—SPP1—multiple sclerosis	1.1e-05	0.000489	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.08e-05	0.000479	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—SPP1—multiple sclerosis	1.07e-05	0.000478	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CCR5—multiple sclerosis	1.07e-05	0.000475	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IL2RA—multiple sclerosis	1.05e-05	0.000469	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CCR5—multiple sclerosis	1.05e-05	0.000465	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—IL2—multiple sclerosis	1.05e-05	0.000465	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—ALB—multiple sclerosis	1.03e-05	0.000459	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IL2RA—multiple sclerosis	1.03e-05	0.000458	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—IL2—multiple sclerosis	1.02e-05	0.000455	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.01e-05	0.00045	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—BCHE—multiple sclerosis	1e-05	0.000447	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—APOE—multiple sclerosis	9.72e-06	0.000432	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—APOE—multiple sclerosis	9.51e-06	0.000423	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CD80—multiple sclerosis	8.79e-06	0.000391	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CD80—multiple sclerosis	8.6e-06	0.000383	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—POMC—multiple sclerosis	8.35e-06	0.000372	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CCL2—multiple sclerosis	8.17e-06	0.000364	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—POMC—multiple sclerosis	8.17e-06	0.000363	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—MAPK1—multiple sclerosis	7.99e-06	0.000356	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CCL2—multiple sclerosis	7.99e-06	0.000356	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—MAPK1—multiple sclerosis	7.82e-06	0.000348	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—TYK2—multiple sclerosis	7.42e-06	0.00033	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—TYK2—multiple sclerosis	7.26e-06	0.000323	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—BCHE—multiple sclerosis	6.19e-06	0.000275	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IL2—multiple sclerosis	6.17e-06	0.000275	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—IL6—multiple sclerosis	6.14e-06	0.000273	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—APOE—multiple sclerosis	6.04e-06	0.000269	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IL2—multiple sclerosis	6.04e-06	0.000269	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—IL6—multiple sclerosis	6.01e-06	0.000267	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MMP9—multiple sclerosis	5.84e-06	0.00026	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MMP9—multiple sclerosis	5.72e-06	0.000254	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—STAT3—multiple sclerosis	5.2e-06	0.000231	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—POMC—multiple sclerosis	5.19e-06	0.000231	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—STAT3—multiple sclerosis	5.08e-06	0.000226	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MYC—multiple sclerosis	4.83e-06	0.000215	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—TGFB1—multiple sclerosis	4.82e-06	0.000214	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ALB—multiple sclerosis	4.73e-06	0.000211	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MAPK1—multiple sclerosis	4.72e-06	0.00021	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MYC—multiple sclerosis	4.72e-06	0.00021	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—TGFB1—multiple sclerosis	4.71e-06	0.00021	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MAPK1—multiple sclerosis	4.62e-06	0.000206	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—APOE—multiple sclerosis	3.72e-06	0.000166	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IL6—multiple sclerosis	3.63e-06	0.000161	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IL6—multiple sclerosis	3.55e-06	0.000158	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—POMC—multiple sclerosis	3.2e-06	0.000142	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ALB—multiple sclerosis	2.92e-06	0.00013	CbGpPWpGaD
